SCHEMBL21696286

SCHEMBL21696286

Cc1cc(CNCCO)cc(C(C)(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.57
ALDH1A1 P00352 1/20 0.41
PDCD1 Q15116 4/20 0.40
CD274 Q9NZQ7 4/20 0.40
SPHK2 Q9NRA0 1/20 0.37
SPHK1 Q9NYA1 1/20 0.37
TACR1 P25103 1/20 0.37
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
SCN2A Q99250 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BCHE P06276 1/20 0.34
BACE1 P56817 1/20 0.34
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
KMT2A Q03164 1/20 0.33
VSIR Q9H7M9 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MITF O75030 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19300879 0.85 GSR (0.39) GSRTACR1SCN2ASMN1; SMN2BCHE
SCHEMBL29037434 0.84 GSR (0.55) GSRALDH1A1PDCD1CD274SPHK2
SCHEMBL15275700 0.79 GSR (0.51) GSRALDH1A1SCN2ABCHEBACE1
SCHEMBL13918962 0.77 BCHE (0.54) GSRPDCD1CD274SMN1; SMN2BCHE
SCHEMBL19051205 0.76 TACR1 (0.43) ALDH1A1TACR1SMN1; SMN2RXRARXRB
SCHEMBL15587609 0.76 GSR (0.47) GSRPDCD1CD274SPHK2SPHK1
SCHEMBL3240028 0.75 GSR (0.54) GSRPDCD1CD274SMN1; SMN2KMT2A
SCHEMBL28264683 0.73 TACR1 (0.46) ALDH1A1TACR1TP53SMN1; SMN2RXRA
SCHEMBL13436123 0.73 GABRA1 (0.44) GSRTACR1BCHEBACE1RXRA
SCHEMBL7933373 0.72 GSR (1.00) GSRALDH1A1TP53ALOX15SCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2800745-B1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORY, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2020-02-12 EP disclosed